Sleep ArchitectureGREENSLEEPNCT07537140
Microgreens on Sleep
A study testing microgreen coctail was given orally in people with Sleep Architecture, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to investigate the effects of Microgreen use on sleep architecture in athletes. Sleep architecture refers to the structural organization of sleep, including the distribution of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep stages, sleep onset latency, total sleep time, and sleep… Read more about this study
- Who is it for?
- Ages 20 to 25 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Sleep Architecture
- What is being tested?
- microgreen coctail was given orally
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Dec 2025to 4 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 25 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- active athlete
Who cannot join
- with no cardiovascular disease
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Çanakkale Onsekiz Mart University
Çanakkale, Çanakkale, 17100
About this study
Official title: Microgreen Consumption and Effects on Sleep Architecture
This study aims to investigate the effects of Microgreen use on sleep architecture in athletes. Sleep architecture refers to the structural organization of sleep, including the distribution of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep stages, sleep onset latency, total sleep time, and sleep efficiency. In athletic populations, optimal sleep is essential for recovery, hormonal regulation, cognitive performance, and physical adaptation.
- Conditions
- Sleep Architecture
- Being tested
- cabbage for control, microgreen coctail was given orally
- Keywords
- sleep quality
- Medical subject headings
- Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
cabbage for controlDietary supplement
cabbage was orally given to control
microgreen coctail was given orallyDietary supplement
microgreen group received orally microgreen coctail
| Study group | Role | What they receive |
|---|---|---|
| control | Experimental | only cabbage received Receives: Dietary Supplement: cabbage for control |
| microgreen | Experimental | microgreen coctail received Receives: Dietary Supplement: microgreen coctail was given orally |
What is being measured
The primary outcome is the main question the study is designed to answer.
DOMS
Fit bitcharge measurements and BORG scale
Measured: From the end of treatment at 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2026
- Study start10 Dec 2025
- Primary completion14 Feb 2026
- Study completion4 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Sleep ArchitectureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Çanakkale Onsekiz Mart University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, DAMLA AYKORA, Çanakkale Onsekiz Mart University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07537140
- Sponsor's protocol ID
- ÇOMU
- Acronym
- GREENSLEEP
- Status last verified
- Apr 2026
- First submitted
- 5 Mar 2026
- Last updated
- 17 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
M Bhaswant
Study at a glance
From the registry record, last updated by the sponsor on 17 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Microgreen Consumption and Effects on Sleep Architecture
- ClinicalTrials.gov ID
- NCT07537140
- Acronym / sponsor ID
- GREENSLEEP / ÇOMU
- Conditions
- Sleep Architecture
- Keywords
- sleep quality
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Çanakkale Onsekiz Mart UniversityUniversity, hospital or other
- Study start
- 10 Dec 2025 (actual)
- Primary completion
- 14 Feb 2026 (actual)
- Study completion
- 4 Mar 2026 (actual)
- First posted
- 17 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effects of Microgreen use on sleep architecture in athletes. Sleep architecture refers to the structural organization of sleep, including the distribution of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep stages, sleep onset latency, total sleep time, and sleep efficiency. In athletic populations, optimal sleep is essential for recovery, hormonal regulation, cognitive performance, and physical adaptation.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| control | Experimental | Dietary Supplement: cabbage for controlonly cabbage received |
| microgreen | Experimental | Dietary Supplement: microgreen coctail was given orallymicrogreen coctail received |
Who may qualify
- Ages
- 20 to 25 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- active athlete
Key exclusion criteria (1 listed)
- with no cardiovascular disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| cabbage for controlcabbage was orally given to control | Dietary supplement | control |
| microgreen coctail was given orallymicrogreen group received orally microgreen coctail | Dietary supplement | microgreen |
Primary outcome
DOMS
Time frame: From the end of treatment at 3 weeks
Fit bitcharge measurements and BORG scale
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Apr 2026.
- BackgroundM Bhaswant
- Individual participant dataSharing planned: No
Related trials for Sleep Architecture
RecruitingObservational study
The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD
Post Traumatic Stress Disorder PTSD
Not yet recruitingPhase 4
Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV
HIV (Human Immunodeficiency Virus), Sleep
Not yet recruitingObservational study
Sleep Architecture, Cognitive Function, and Quality of Life During Early Recovery From Substance Use Disorder
Substance-Related Disorders, Substance Use Disorder
Active, not recruitingObservational study
Brain Age and Sleep Architecture in Meditators
Brain Age
Active, not recruiting
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor
Sleep-Disordered Breathing, Sleep Architecture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing microgreen coctail was given orally in people with Sleep Architecture, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
DOMS (time frame: From the end of treatment at 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07537140, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.